Nearshoring & Reshoring

Telit Cinterion's US move isn't just about jobs. It's a strategic pivot towards resilience, securing the digital backbone of a volatile world.

A new deal between miner Elevra and refiner Mangrove, backed by Ottawa's strategic investment, creates a complete Canadian lithium supply chain from mine to battery material.

The global auto supplier isn't just opening a factory. Its Atlanta move, coupled with new vision, access, and sensing tech, is a strategic play for the future of the car.

As U.S. agencies define a new "intermediate force" market, French innovator NETFORCE arrives with a patented stun glove and a plan to build in America.

The upcoming Hardlines Supplier Event isn't just another trade show. It's a data-driven answer to the supply chain chaos plaguing a multi-billion dollar industry.

Volvo CE's major U.S. manufacturing expansion is more than a factory upgrade; it's a masterclass in building supply chain resilience for a new era.

Kubota's $300M+ Salina expansion is more than new jobs. It's a strategic play to onshore production, fortify supply chains, and dominate North America.

With its new Bogotá center, Auxis taps into Colombia's booming bilingual talent pool, offering U.S. businesses a resilient alternative to far-flung operations.

A private equity firm's acquisition of a wastewater company reveals a deeper story about water scarcity, reshoring, and the systems we need to thrive.

A new partnership is bringing advanced, U.S.-based manufacturing to a rare cancer drug, aiming to solve daily patient challenges and bolster national supply chains.

Beyond the headline, Stanley Black & Decker's billion-dollar investment is a blueprint for tackling the skilled labor crisis and reshoring America's future.

The US lost its magnet-making workforce decades ago. A new partnership uses AI to train a new generation, securing our technological future.

FutureFuel's stunning $25.6M profit swing reveals a blueprint for resilience, powered by regulatory tailwinds in biofuels and reshoring in chemicals.

Bristol Myers Squibb's massive Texas campus isn't just about jobs. It's a high-tech play to reshore drug manufacturing and revolutionize how we make medicine.

In a strategic move, Xcellon acquires a GMP facility, aiming to become a key CRDMO for complex biologics and bolster America's biotech supply chain.

The White House's sweeping new tariffs on polysilicon aim to rebuild America's solar supply chain, but the move has split the industry.

A Quebec manufacturer's $5M funding isn't just about window blinds. It's a blueprint for turning trade wars into growth via automation and smart alliances.

Italy's oldest pasta maker is planting its US flag in St. Charles, Missouri. This isn't just about pasta; it's a calculated play for market control.

The silicon giant reports a stunning return to profitability, but a deep dive reveals a massive one-time energy contract gain, not just operational muscle.

A strategic investment in Carolina Components Group signals a larger PE trend: fortifying the single-use technology supply chain to de-risk drug manufacturing.